Doctor-led aesthetics in Sutton Coldfield
MDr MaryamAesthetics

Profhilo

Profhilo with anti-wrinkle treatment: what did the 2026 trial find?

A small 2026 study found no additional short-term improvement in forehead wrinkles or ultrasound measurements when Profhilo was added to an anti-wrinkle treatment.

5 minute read

Two treatments do not automatically produce a better result

Profhilo and prescription anti-wrinkle treatment act in different ways. Profhilo is a hyaluronic-acid injectable intended to support hydration, tone and selected aspects of skin quality. Anti-wrinkle treatment reduces activity in chosen muscles. Combining them may sound logical, but a plausible theory is not the same as evidence of extra benefit.

The first question should be what the patient wants to change. Forehead lines caused mainly by repeated movement are different from dryness, reduced elasticity, sun damage or lines that remain at rest. Adding another injectable cannot be assumed to address every layer of ageing or to improve a result that is already appropriate.

What did the 2026 study compare?

A prospective clinical trial included 20 adults. Ten received an upper-face anti-wrinkle treatment together with Profhilo, while ten age- and sex-matched participants received the anti-wrinkle treatment alone. Researchers compared clinical wrinkle scores and ultrasound measurements three months after the final session.

Forehead wrinkle scores improved in both groups. However, the difference between the combined-treatment group and the single-treatment group was not statistically significant. Ultrasound measurements of dermal and deeper tissue thickness and elasticity also showed no significant change in either group.

The trial did not show an added short-term advantage

For the specific outcome tested—forehead wrinkle reduction over three months—the study did not demonstrate that adding Profhilo improved the result. This is important because more treatment means more injections, cost and recovery, and those burdens need a clear potential benefit rather than an assumption that a combination must be superior.

The finding does not prove that Profhilo has no effect on skin quality, or that the two treatments should never be considered in the same person. It means this small study did not establish an additional short-term benefit for the forehead measures it selected. Hydration, texture or another area may require different outcomes and separate evidence.

Why the result needs cautious interpretation

Each group contained only ten people, most participants were men, and follow-up lasted three months. A study of this size can miss modest differences and uncommon adverse effects. The comparison was not designed to tell us the best interval between treatments, whether a different injection plan would change the result or what happens beyond the study period.

A 2026 systematic review identified nine Profhilo and Profhilo Body studies with 278 participants across several treatment areas. It reported improvement trends but also wide variation in study methods and outcomes. Evidence from the face, neck, arms or body should not be treated as interchangeable, and average results cannot predict an individual response.

Combination planning should not be a standard package

If both treatments are being considered, each should have its own goal. The consultation should document which lines move with expression, which remain at rest and whether skin quality is a meaningful concern. Consistent photographs and a planned review help separate response from expectation before another procedure is added.

Timing also matters. Closely spaced procedures can create overlapping redness, swelling, tenderness or bruising and make it harder to know which treatment caused a reaction. The manufacturer states that Profhilo must not be mixed with other products. Any combined plan should therefore use each product according to its instructions and be individually sequenced by qualified clinicians.

Downtime, adverse effects and suitability

Profhilo injection sites may temporarily develop pain, warmth, itching, burning, redness, bruising, oedema, swelling or visible raised points. The separate anti-wrinkle procedure has its own local and uncommon serious risks. Increasing pain, spreading redness or heat, discharge, fever, unusual skin colour or worsening swelling needs prompt clinical advice; urgent symptoms require immediate help.

Medical history, medicines, allergies, previous reactions, pregnancy or breastfeeding, autoimmune disease, active inflammation and planned skin procedures must be reviewed. The anti-wrinkle component also requires an appropriate prescribing consultation and physical assessment. GMC guidance requires honest discussion of evidence, alternatives, risks and follow-up. Sometimes one treatment, staged treatment or no injectable is the more proportionate choice.

← Back to the journal

Personalised medical assessment

Questions about treatment?

Book a consultation to discuss your concerns, health and treatment options without pressure.

Free consultation – a £1 booking fee secures your appointment